Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIRS to Elucidate Cortical Brain Cytochrome C Oxidase Activity in Bipolar Disorder
NCT07806227Phase 4Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 4 trial of lurasidone in bipolar disorder (BD). Planned start Nov 2026; status: not yet recruiting.
02
Drugs
lurasidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT07806227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07806227.